Table 3.

Associations With Use of Inhaled Antiinflammatory Medication Daily Among 107 Children With Asthma Who Had Been Hospitalized During the Previous 12 Months and/or Use Daily β2-Agonist in Two East Harlem Elementary Schools

FactorNumberProportion Using an
Inhaled Antiinflammatory
Medication Daily
95% CIAOR 95% CI
 Household income
  ≤$10 000/y4531%Reference
  >$10 000/y5147%1.19.78, 4.80
  Unknown1145%1.82.40, 8.21
  Puerto Rican5052%Reference
  Black3330%.40.14, 1.11 .32.12, .89
  Other2129%.31.11, 1.24 .27.09, .85
  4–9 y7540%Reference
  10 or more y3238%.90.38, 2.12
  Boys6543%1.4.62, 3.18
Use of health care
 Last visit with physician
 to check asthma
  >6 mo ago2119%Reference
  ≤6 mo ago8644%3.361.09, 10.413.461.01, 11.9
 Asthma management plan
 with physician
  Do not have1011%Reference
  Have9743%5.86.87, 39.32
Asthma devices
 Do not have peak flow meter7634%Reference
 Have a peak flow meter3152%2.05.89, 4.78
 Do not have a spacer tube6231%Reference
 Have a spacer4551%2.371.07,, 7.47
Severity indicators
 Have 2 symptoms or less4127%Reference
 Have ≥3 symptoms past 12 mo6647%2.411.05, 5.58
 Did not use emergency department1520%Reference
 Used emergency department
 in previous 12 mo
9243%3.06.84, 11.10
 Not absent from school during
 previous mo
 Absent from school during
 previous mo
7342%1.54.65, 3.63
 Did not stop participating in sports4132%Reference
 Stopped participating in sports
 in past mo
6242%1.56.68, 3.57
  • * Inhaled steroid or cromolyn/nedocromil.

  • Logistic regression model created by backward elimination.

  • Not included in model.